Skip to main content
Top
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells

Authors: Tomoki Sumida, Ryuichi Murase, Akiko Onishi-Ishikawa, Sean D McAllister, Hiroyuki Hamakawa, Pierre-Yves Desprez

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

Salivary gland cancer (SGC) is one of the common malignancies of the head and neck area. It develops in the minor and major salivary glands and sometimes metastasizes to other organs, particularly to the lungs. Inhibitors of differentiation (Id) proteins are negative regulators of basic helix-loop-helix transcription factors that control malignant cell behavior and tumor aggressiveness in many tissues. In this study, our goal was to determine the potential role of Id proteins, particularly Id1, during human SGC cell progression.

Methods

We first determined the expression levels of Id1 and Id2 in four SGC cell lines: two adenocarcinoma of the salivary gland (HSG and HSY) and two adenoid cystic carcinoma (ACC2 and ACCM) cell lines. We then used constructs that expressed antisense cDNAs to Id1 or Id2 to knockdown the expression of these proteins in cell lines where they were highly expressed, and determined the effects of the knockdown on cell proliferation, migration and invasion.

Results

Id1 mRNA and protein were detectable in all cell lines, and expression of Id2 was variable, from absent to high. The ACC2 and ACCM cell lines expressed both Id1 and Id2, but Id1 was expressed at a higher level in the more aggressive ACCM cell line in comparison toACC2 cells as confirmed by Id1 promoter-reporter assays. We therefore focused on the ACCM cells for the remainder of the study. We found that proliferation and invasiveness of ACCM cells were strongly reduced after Id1 knockdown whereas Id2 suppression had only a slight effect. Results of scratch and colony formation assays also confirmed that ACCM cell aggressiveness was significantly reduced upon Id1 knockdown. Finally, this knockdown resulted in reduced c-myc and enhanced cyclin-dependent kinase inhibitor p21 expression.

Conclusions

These results demonstrate that Id1 plays an important role in the control of human SGC cell aggressiveness and suggest a potential role as a marker of diagnosis, prognosis and progression of SGCs. Id1 suppression could represent a novel and effective approach for the treatment of salivary gland cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lima SS, Soares AF, de Amorim RF, Freitas RA: Epidemiologic profile of salivary gland neoplasms: analysis of 245 cases. Rev Bras Otorrinolaringol. 2005, 71: 335-340. 10.1590/S0034-72992005000300012.CrossRef Lima SS, Soares AF, de Amorim RF, Freitas RA: Epidemiologic profile of salivary gland neoplasms: analysis of 245 cases. Rev Bras Otorrinolaringol. 2005, 71: 335-340. 10.1590/S0034-72992005000300012.CrossRef
2.
go back to reference Toida M, Shimokawa K, Makita H, Kato K, Kobayashi A, Kusunoki Y, Hatakeyama D, Fujitsuka H, Yamashita T, Shibata T: Intraoral minor salivary gland tumors: a clinicopathological study of 82 cases. Int J Oral Maxillofac Surg. 2005, 34: 528-532. 10.1016/j.ijom.2004.10.010.CrossRefPubMed Toida M, Shimokawa K, Makita H, Kato K, Kobayashi A, Kusunoki Y, Hatakeyama D, Fujitsuka H, Yamashita T, Shibata T: Intraoral minor salivary gland tumors: a clinicopathological study of 82 cases. Int J Oral Maxillofac Surg. 2005, 34: 528-532. 10.1016/j.ijom.2004.10.010.CrossRefPubMed
3.
go back to reference Lopes MA, Santos GC, Kowalski LP: Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck. 1998, 20: 699-706. 10.1002/(SICI)1097-0347(199812)20:8<699::AID-HED7>3.0.CO;2-P.CrossRefPubMed Lopes MA, Santos GC, Kowalski LP: Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck. 1998, 20: 699-706. 10.1002/(SICI)1097-0347(199812)20:8<699::AID-HED7>3.0.CO;2-P.CrossRefPubMed
4.
go back to reference Jones AS, Hamilton JW, Rowley H, Husband D, Helliwell TR: Adenoid cystic carcinoma of the head and neck. Clin Otolaryngol Allied Sci. 1997, 22: 434-443. 10.1046/j.1365-2273.1997.00041.x.CrossRefPubMed Jones AS, Hamilton JW, Rowley H, Husband D, Helliwell TR: Adenoid cystic carcinoma of the head and neck. Clin Otolaryngol Allied Sci. 1997, 22: 434-443. 10.1046/j.1365-2273.1997.00041.x.CrossRefPubMed
5.
go back to reference Spiro RH: Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surgery. 1997, 174: 495-498. 10.1016/S0002-9610(97)00153-0.CrossRef Spiro RH: Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surgery. 1997, 174: 495-498. 10.1016/S0002-9610(97)00153-0.CrossRef
6.
go back to reference Marandas P, Dharkar D, Davis A, Leridant AM, Pacheco Ojeda L, Micheau C, Wibault P, Schwaab G: Malignant tumours of the parotid: a study of 76 patients. Clin Otolaryngol. 1990, 15: 103-109. 10.1111/j.1365-2273.1990.tb00441.x.CrossRefPubMed Marandas P, Dharkar D, Davis A, Leridant AM, Pacheco Ojeda L, Micheau C, Wibault P, Schwaab G: Malignant tumours of the parotid: a study of 76 patients. Clin Otolaryngol. 1990, 15: 103-109. 10.1111/j.1365-2273.1990.tb00441.x.CrossRefPubMed
7.
go back to reference Takagi D, Fukuda S, Furuta Y, Yagi K, Homma A, Nagahashi T, Inuyama Y: Clinical study of adenoid cystic carcinoma of the head and neck. Auris Nasus Larynx. 2001, 28: S99-102.CrossRefPubMed Takagi D, Fukuda S, Furuta Y, Yagi K, Homma A, Nagahashi T, Inuyama Y: Clinical study of adenoid cystic carcinoma of the head and neck. Auris Nasus Larynx. 2001, 28: S99-102.CrossRefPubMed
8.
go back to reference Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM: Id proteins in cell growth and tumorigenesis. Cancer Cell. 2003, 3: 525-530. 10.1016/S1535-6108(03)00141-7.CrossRefPubMed Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM: Id proteins in cell growth and tumorigenesis. Cancer Cell. 2003, 3: 525-530. 10.1016/S1535-6108(03)00141-7.CrossRefPubMed
9.
go back to reference Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H: The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 1990, 61: 49-59. 10.1016/0092-8674(90)90214-Y.CrossRefPubMed Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H: The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 1990, 61: 49-59. 10.1016/0092-8674(90)90214-Y.CrossRefPubMed
10.
go back to reference Norton JD, Deed RW, Craggs G, Sablitzky F: Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 1998, 8: 58-65.PubMed Norton JD, Deed RW, Craggs G, Sablitzky F: Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 1998, 8: 58-65.PubMed
11.
go back to reference Norton JD: ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci. 2000, 113: 3897-3905.PubMed Norton JD: ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci. 2000, 113: 3897-3905.PubMed
12.
go back to reference Riechmann V, van Crüchten I, Sablitzky F: The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3. Nucleic Acids Res. 1994, 22: 749-755. 10.1093/nar/22.5.749.CrossRefPubMedPubMedCentral Riechmann V, van Crüchten I, Sablitzky F: The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3. Nucleic Acids Res. 1994, 22: 749-755. 10.1093/nar/22.5.749.CrossRefPubMedPubMedCentral
13.
go back to reference Riechmann V, Sablitzky F: Mutually exclusive expression of two dominant-negative helix-loop-helix (dnHLH) genes, ld4 and ld3, in the developing brain of the mouse suggests distinct regulatory roles of these dnHLH proteins during cellular proliferation and differentiation of the nervous system. Cell Growth Differ. 1995, 6: 837-843.PubMed Riechmann V, Sablitzky F: Mutually exclusive expression of two dominant-negative helix-loop-helix (dnHLH) genes, ld4 and ld3, in the developing brain of the mouse suggests distinct regulatory roles of these dnHLH proteins during cellular proliferation and differentiation of the nervous system. Cell Growth Differ. 1995, 6: 837-843.PubMed
14.
go back to reference Lee YS, Kang JW, Lee YH, Kim DW: ID4 mediates proliferation of astrocytes after excitotoxic damage in the mouse hippocampus. Anat Cell Biol. 2011, 44: 128-134. 10.5115/acb.2011.44.2.128.CrossRefPubMedPubMedCentral Lee YS, Kang JW, Lee YH, Kim DW: ID4 mediates proliferation of astrocytes after excitotoxic damage in the mouse hippocampus. Anat Cell Biol. 2011, 44: 128-134. 10.5115/acb.2011.44.2.128.CrossRefPubMedPubMedCentral
15.
go back to reference Kuzontkoski PM, Mulligan-Kehoe MJ, Harris BT, Israel MA: Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels. Oncogene. 2010, 29: 3793-802. 10.1038/onc.2010.147.CrossRefPubMed Kuzontkoski PM, Mulligan-Kehoe MJ, Harris BT, Israel MA: Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels. Oncogene. 2010, 29: 3793-802. 10.1038/onc.2010.147.CrossRefPubMed
16.
go back to reference Lowery JW, Frump AL, Anderson L, DiCarlo GE, Jones MT, de Caestecker MP: ID family protein expression and regulation in hypoxic pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol. 2010, 299: 1463-1477. 10.1152/ajpregu.00866.2009.CrossRef Lowery JW, Frump AL, Anderson L, DiCarlo GE, Jones MT, de Caestecker MP: ID family protein expression and regulation in hypoxic pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol. 2010, 299: 1463-1477. 10.1152/ajpregu.00866.2009.CrossRef
17.
go back to reference Sato N, Kyakumoto S, Sawano K, Ota M: Proliferative signal transduction by epidermal growth factor (EGF) in the human salivary gland adenocarcinoma (HSG) cell line. Biochem Mol Biol Int. 1996, 38: 597-606.PubMed Sato N, Kyakumoto S, Sawano K, Ota M: Proliferative signal transduction by epidermal growth factor (EGF) in the human salivary gland adenocarcinoma (HSG) cell line. Biochem Mol Biol Int. 1996, 38: 597-606.PubMed
18.
go back to reference Myoken Y, Myoken Y, Okamoto T, Kan M, McKeehan WL, Sato JD, Takada K: Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary-gland adenocarcinoma cell line: evidence of growth. Int J Cancer. 1996, 65: 650-657. 10.1002/(SICI)1097-0215(19960301)65:5<650::AID-IJC15>3.0.CO;2-B.CrossRefPubMed Myoken Y, Myoken Y, Okamoto T, Kan M, McKeehan WL, Sato JD, Takada K: Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary-gland adenocarcinoma cell line: evidence of growth. Int J Cancer. 1996, 65: 650-657. 10.1002/(SICI)1097-0215(19960301)65:5<650::AID-IJC15>3.0.CO;2-B.CrossRefPubMed
19.
go back to reference Guan XF, Qiu WL, He RG, Zhou XJ: Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study. Int J Oral Maxillofac Surg. 1997, 26: 116-119.CrossRefPubMed Guan XF, Qiu WL, He RG, Zhou XJ: Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study. Int J Oral Maxillofac Surg. 1997, 26: 116-119.CrossRefPubMed
20.
go back to reference Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. 1989, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. 1989, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
21.
go back to reference Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987, 162: 156-159.CrossRefPubMed Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987, 162: 156-159.CrossRefPubMed
22.
go back to reference Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K: Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem. 1994, 269: 2139-2145.PubMed Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K: Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem. 1994, 269: 2139-2145.PubMed
23.
go back to reference Parrinello S, Lin CQ, Murata K, Itahana Y, Singh J, Krtolica A, Campisi J, Desprez PY: Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J Biol Chem. 2001, 276: 39213-39219. 10.1074/jbc.M104473200.CrossRefPubMed Parrinello S, Lin CQ, Murata K, Itahana Y, Singh J, Krtolica A, Campisi J, Desprez PY: Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J Biol Chem. 2001, 276: 39213-39219. 10.1074/jbc.M104473200.CrossRefPubMed
24.
go back to reference Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, Desprez PY: A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res. 2000, 60: 1332-1340.PubMed Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, Desprez PY: A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res. 2000, 60: 1332-1340.PubMed
25.
go back to reference Morgenstern JP, Land H: Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helperfree packaging cell line. Nucleic Acids Res. 1990, 18: 3587-3596. 10.1093/nar/18.12.3587.CrossRefPubMedPubMedCentral Morgenstern JP, Land H: Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helperfree packaging cell line. Nucleic Acids Res. 1990, 18: 3587-3596. 10.1093/nar/18.12.3587.CrossRefPubMedPubMedCentral
26.
go back to reference Gorman C: High efficiency gene transfer into mammalian cell. DNA Cloning. Edited by: Glover DM. 1986, Oxford, United Kingdom: IRL, 143-211. Gorman C: High efficiency gene transfer into mammalian cell. DNA Cloning. Edited by: Glover DM. 1986, Oxford, United Kingdom: IRL, 143-211.
27.
go back to reference Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ, Campisi J: A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol Cell Biol. 1998, 18: 4577-4588.CrossRefPubMedPubMedCentral Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ, Campisi J: A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol Cell Biol. 1998, 18: 4577-4588.CrossRefPubMedPubMedCentral
28.
go back to reference Israel MA, Hernandez MC, Florio M, Andres-Barquin PJ, Mantani A, Carter JH, Julin CM: Id gene expression as a key mediator of tumor cell biology. Cancer Res. 1999, 59: 1726-1730. Israel MA, Hernandez MC, Florio M, Andres-Barquin PJ, Mantani A, Carter JH, Julin CM: Id gene expression as a key mediator of tumor cell biology. Cancer Res. 1999, 59: 1726-1730.
29.
go back to reference Maruyama H, Kleeff J, Wildi S, Friess H, Büchler MW, Israel MA, Korc M: Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol. 1999, 155: 815-822. 10.1016/S0002-9440(10)65180-2.CrossRefPubMedPubMedCentral Maruyama H, Kleeff J, Wildi S, Friess H, Büchler MW, Israel MA, Korc M: Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol. 1999, 155: 815-822. 10.1016/S0002-9440(10)65180-2.CrossRefPubMedPubMedCentral
30.
go back to reference Yuen HF, Chan YP, Chan KK, Chu YY, Wong ML, Law SY, Srivastava G, Wong YC, Wang X, Chan KW: Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer. 2007, 97: 1409-1415. 10.1038/sj.bjc.6604035.CrossRefPubMedPubMedCentral Yuen HF, Chan YP, Chan KK, Chu YY, Wong ML, Law SY, Srivastava G, Wong YC, Wang X, Chan KW: Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer. 2007, 97: 1409-1415. 10.1038/sj.bjc.6604035.CrossRefPubMedPubMedCentral
31.
go back to reference Asirvatham AJ, Carey JP, Chaudhary J: ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells. Prostate. 2007, 67: 1411-1420. 10.1002/pros.20633.CrossRefPubMed Asirvatham AJ, Carey JP, Chaudhary J: ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells. Prostate. 2007, 67: 1411-1420. 10.1002/pros.20633.CrossRefPubMed
32.
go back to reference Yoshimura T, Sumida T, Liu S, Onishi A, Shintani S, Desprez PY, Hamakawa H: Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment. Endocr Relat Cancer. 2007, 14: 1107-1116. 10.1677/erc.1.01253.CrossRefPubMed Yoshimura T, Sumida T, Liu S, Onishi A, Shintani S, Desprez PY, Hamakawa H: Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment. Endocr Relat Cancer. 2007, 14: 1107-1116. 10.1677/erc.1.01253.CrossRefPubMed
33.
go back to reference Sumida T, Itahana Y, Hamakawa H, Desprez PY: Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form A or B of the progesterone receptor and then treatment with progestins. Cancer Res. 2004, 64: 7886-7892. 10.1158/0008-5472.CAN-04-1155.CrossRefPubMed Sumida T, Itahana Y, Hamakawa H, Desprez PY: Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form A or B of the progesterone receptor and then treatment with progestins. Cancer Res. 2004, 64: 7886-7892. 10.1158/0008-5472.CAN-04-1155.CrossRefPubMed
Metadata
Title
Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells
Authors
Tomoki Sumida
Ryuichi Murase
Akiko Onishi-Ishikawa
Sean D McAllister
Hiroyuki Hamakawa
Pierre-Yves Desprez
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-141

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine